<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US5958946 - Applying glucuronic acid - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Applying glucuronic acid"><meta name="DC.contributor" content="Peter Styczynski" scheme="inventor"><meta name="DC.contributor" content="Gurpreet S. Ahluwalia" scheme="inventor"><meta name="DC.contributor" content="Styczynski; Peter" scheme="assignee"><meta name="DC.contributor" content="Ahluwalia; Gurpreet S." scheme="assignee"><meta name="DC.date" content="1998-1-20" scheme="dateSubmitted"><meta name="DC.description" content="Mammalian hair growth may be modulated by applying to the skin a compound that induces or activates the conjugation of an androgen."><meta name="DC.date" content="1999-9-28" scheme="issued"><meta name="DC.relation" content="EP:0413528:A1" scheme="references"><meta name="DC.relation" content="EP:0532219:A2" scheme="references"><meta name="DC.relation" content="GB:1458349" scheme="references"><meta name="DC.relation" content="US:3426137" scheme="references"><meta name="DC.relation" content="US:4039669" scheme="references"><meta name="DC.relation" content="US:4139638" scheme="references"><meta name="DC.relation" content="US:4161540" scheme="references"><meta name="DC.relation" content="US:4191775" scheme="references"><meta name="DC.relation" content="US:4269831" scheme="references"><meta name="DC.relation" content="US:4370315" scheme="references"><meta name="DC.relation" content="US:4439432" scheme="references"><meta name="DC.relation" content="US:4508714" scheme="references"><meta name="DC.relation" content="US:4517175" scheme="references"><meta name="DC.relation" content="US:4720489" scheme="references"><meta name="DC.relation" content="US:4885289" scheme="references"><meta name="DC.relation" content="US:4935231" scheme="references"><meta name="DC.relation" content="US:5095007" scheme="references"><meta name="DC.relation" content="US:5096911" scheme="references"><meta name="DC.relation" content="US:5132293" scheme="references"><meta name="DC.relation" content="US:5143925" scheme="references"><meta name="DC.relation" content="US:5189212" scheme="references"><meta name="DC.relation" content="US:5271942" scheme="references"><meta name="DC.relation" content="US:5300284" scheme="references"><meta name="DC.relation" content="US:5364885" scheme="references"><meta name="DC.relation" content="US:5411991" scheme="references"><meta name="DC.relation" content="US:5455234" scheme="references"><meta name="DC.relation" content="US:5474763" scheme="references"><meta name="DC.relation" content="US:5554608" scheme="references"><meta name="DC.relation" content="US:5648394" scheme="references"><meta name="DC.relation" content="WO:1996010387:A2" scheme="references"><meta name="citation_reference" content="Adachi et al., &quot;Human Hair Follicles: Metabolism and Control Mechanisms&quot;, Journal of the Society of Cosmetic Chemists, 21, 901-924, Dec. 9, 1970."><meta name="citation_reference" content="Adachi et al., Human Hair Follicles: Metabolism and Control Mechanisms , Journal of the Society of Cosmetic Chemists, 21, 901 924, Dec. 9, 1970."><meta name="citation_reference" content="Andrew G. Messenger, &quot;The Control of Hair Growth: An Overview&quot;, The Society for Investigative Dermatology, Inc., 1993."><meta name="citation_reference" content="Andrew G. Messenger, The Control of Hair Growth: An Overview , The Society for Investigative Dermatology, Inc., 1993."><meta name="citation_reference" content="CA 123:4198, Kudlacek et, 1995."><meta name="citation_reference" content="CA 125:293042, Ahlowaha et al, 1996."><meta name="citation_reference" content="Chen et al., &quot;Characterization of a Cloned Human Dihydrotestosterone/Androstanediol UDP-Glucuronosyltrans-ferase and Its Comparison to Other Steroid Isoforms&quot;, Biochemistry, vol. 32, No. 40, 10648-57, 1993."><meta name="citation_reference" content="Chen et al., Characterization of a Cloned Human Dihydrotestosterone/Androstanediol UDP Glucuronosyltrans ferase and Its Comparison to Other Steroid Isoforms , Biochemistry, vol. 32, No. 40, 10648 57, 1993."><meta name="citation_reference" content="Green et al., &quot;Cloning and Expression of a Rat Liver Phenobarbital-Inducible UDP-Glucuronosyltransferase (2B12) with Specificity for Monoterpenoid Alcohols&quot;, Arch. of Biochem. &amp; Biophysics, vol. 322, Oct. 1, 1995."><meta name="citation_reference" content="Green et al., Cloning and Expression of a Rat Liver Phenobarbital Inducible UDP Glucuronosyltransferase (2B12) with Specificity for Monoterpenoid Alcohols , Arch. of Biochem. &amp; Biophysics, vol. 322, Oct. 1, 1995."><meta name="citation_reference" content="J. Baron, &quot;In situ sites for xenobiotic activation and detoxication: Implications for the differential susceptibility of cells to the toxic . . . &quot;, Progress in Histo-and Cytochemistry, vol. 23, 1991."><meta name="citation_reference" content="J. Baron, In situ sites for xenobiotic activation and detoxication: Implications for the differential susceptibility of cells to the toxic . . . , Progress in Histo and Cytochemistry, vol. 23, 1991."><meta name="citation_reference" content="Kashfi et al., &quot;Regulation of Uridine Diphosphate Glucuronosyltransferase Expression by Phenolic Antioxidants&quot;, Cancer Research, 54, pp. 5856-5859, Nov. 15, 1994."><meta name="citation_reference" content="Kashfi et al., Regulation of Uridine Diphosphate Glucuronosyltransferase Expression by Phenolic Antioxidants , Cancer Research, 54, pp. 5856 5859, Nov. 15, 1994."><meta name="citation_reference" content="Marty E. Sawaya, &quot;Steroid Chemistry and Hormone Controls during the Hair Follicle Cycle&quot;, Annals New York Academy of Sciences, pp. 376-384 (Undated)."><meta name="citation_reference" content="Marty E. Sawaya, Steroid Chemistry and Hormone Controls during the Hair Follicle Cycle , Annals New York Academy of Sciences, pp. 376 384 (Undated)."><meta name="citation_reference" content="Michael R. Franklin, &quot;Drug Metabolizing Enzyme Induction by Simple Diaryl Pydridines; 2-Substituted Isomers Selectively Increase Only Conjugation Enzyme Activities . . . &quot;, Toxicology and Applied Pharmacology, 111, 1991."><meta name="citation_reference" content="Michael R. Franklin, Drug Metabolizing Enzyme Induction by Simple Diaryl Pydridines; 2 Substituted Isomers Selectively Increase Only Conjugation Enzyme Activities . . . , Toxicology and Applied Pharmacology, 111, 1991."><meta name="citation_reference" content="Pegg et al., &quot;Fundam. Appl. Toxicol.&quot;, vol. 32(1):45-32, (1996) (Abstract only)."><meta name="citation_reference" content="Pegg et al., Fundam. Appl. Toxicol. , vol. 32(1):45 32, (1996) (Abstract only)."><meta name="citation_reference" content="Pritchard et al., &quot;A Recombinant Phenobarbital-Inducible Rat Liver UDP-Glucoronsyltransferase (UDP-Glucuro-nosyltransferase 2B1) Stably Expressed in V79 Cells Catalyzes . . . &quot; Molecular Pharmacology, 45:42-50, 1993."><meta name="citation_reference" content="Pritchard et al., A Recombinant Phenobarbital Inducible Rat Liver UDP Glucoronsyltransferase (UDP Glucuro nosyltransferase 2B1) Stably Expressed in V79 Cells Catalyzes . . . Molecular Pharmacology, 45:42 50, 1993."><meta name="citation_reference" content="Ritter et al., &quot;Induction of Hepatic Oxidative and Conjugative Drug Metabolism in the Hamster by N-Substituted Imidazoles&quot;, Toxicology Letters, 36, pp. 51-59, 1987."><meta name="citation_reference" content="Ritter et al., Induction of Hepatic Oxidative and Conjugative Drug Metabolism in the Hamster by N Substituted Imidazoles , Toxicology Letters, 36, pp. 51 59, 1987."><meta name="citation_reference" content="Schweikert et al., Regulation of Human Hair Growth by Steroid Hormones, JCE&amp;M, vol. 38, No. 5, 1974."><meta name="citation_reference" content="Sun et al., &quot;Flavonoids increased the activity of Testosterone Glucuronosyltransferase (GT) in prostate cancer cells&quot;, Proceedings of the American Association for Cancer Research, vol. 36, Mar. 1995 (Abstract)."><meta name="citation_reference" content="Sun et al., Flavonoids increased the activity of Testosterone Glucuronosyltransferase (GT) in prostate cancer cells , Proceedings of the American Association for Cancer Research, vol. 36, Mar. 1995 (Abstract)."><meta name="citation_reference" content="Tephyl et al., &quot;UDP-glucuronosyltransferases: a family of detoxifying enzymes&quot;, TIPS Reviews, Jul. 1990."><meta name="citation_reference" content="Tephyl et al., UDP glucuronosyltransferases: a family of detoxifying enzymes , TIPS Reviews, Jul. 1990."><meta name="citation_reference" content="Wong et al., &quot;Differential Induction of UDP-Glucuronosyltransferase Activity and Gene Expression in Rat Liver&quot;, Pharmaceutical Research, vol. 12, No. 7, 1995."><meta name="citation_reference" content="Wong et al., Differential Induction of UDP Glucuronosyltransferase Activity and Gene Expression in Rat Liver , Pharmaceutical Research, vol. 12, No. 7, 1995."><meta name="citation_patent_number" content="US:5958946"><meta name="citation_patent_application_number" content="US:09/009,213"><link rel="canonical" href="http://www.google.com/patents/US5958946"/><meta property="og:url" content="http://www.google.com/patents/US5958946"/><meta name="title" content="Patent US5958946 - Applying glucuronic acid"/><meta name="description" content="Mammalian hair growth may be modulated by applying to the skin a compound that induces or activates the conjugation of an androgen."/><meta property="og:title" content="Patent US5958946 - Applying glucuronic acid"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("DynuU4CNPNCmsQSl6IH4BQ"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("PRT"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("DynuU4CNPNCmsQSl6IH4BQ"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("PRT"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us5958946?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US5958946"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=xkRMBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS5958946&amp;usg=AFQjCNE5mX9bNpTwniGhBE3W6r7Q-oTQ2w" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5958946.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US5958946.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US5958946" style="display:none"><span itemprop="description">Mammalian hair growth may be modulated by applying to the skin a compound that induces or activates the conjugation of an androgen....</span><span itemprop="url">http://www.google.com/patents/US5958946?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US5958946 - Applying glucuronic acid</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US5958946 - Applying glucuronic acid" title="Patent US5958946 - Applying glucuronic acid"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US5958946 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 09/009,213</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Sep 28, 1999</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Jan 20, 1998</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Jan 20, 1998</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2320160A1">CA2320160A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2320160C">CA2320160C</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69935778D1">DE69935778D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69935778T2">DE69935778T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69935778T3">DE69935778T3</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1047420A1">EP1047420A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1047420A4">EP1047420A4</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1047420B1">EP1047420B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1047420B2">EP1047420B2</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1999036067A1">WO1999036067A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">009213, </span><span class="patent-bibdata-value">09009213, </span><span class="patent-bibdata-value">US 5958946 A, </span><span class="patent-bibdata-value">US 5958946A, </span><span class="patent-bibdata-value">US-A-5958946, </span><span class="patent-bibdata-value">US5958946 A, </span><span class="patent-bibdata-value">US5958946A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Peter+Styczynski%22">Peter Styczynski</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Gurpreet+S.+Ahluwalia%22">Gurpreet S. Ahluwalia</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Styczynski%3B+Peter%22">Styczynski; Peter</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Ahluwalia%3B+Gurpreet+S.%22">Ahluwalia; Gurpreet S.</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5958946.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5958946.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5958946.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (30),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (31),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (27),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (45),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (6)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/5958946&usg=AFQjCNFURtFlVAZHSx3Zt3kDb6LOQhMmJg">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D5958946&usg=AFQjCNFRa2PjKAtHImLlRg1bllVwwmCVeQ">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D5958946A%26KC%3DA%26FT%3DD&usg=AFQjCNEuMmpSSssbDJ9EiCt5yNa8aXpWyA">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT129159467" lang="EN" load-source="ifi">Applying glucuronic acid</invention-title></span><br><span class="patent-number">US 5958946 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA37965678" lang="EN" load-source="patent-office"> <div class="abstract">Mammalian hair growth may be modulated by applying to the skin a compound that induces or activates the conjugation of an androgen.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(8)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5958946-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5958946-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5958946-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5958946-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5958946-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5958946-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5958946-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5958946-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5958946-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5958946-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5958946-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5958946-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5958946-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5958946-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5958946-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5958946-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(39)</span></span></div><div class="patent-text"><div mxw-id="PCLM5449911" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>We claim:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A method of inducing or activating uridine diphosphate-glucouronosyltransferase to catalyze conjugation of an androgen involved in hair growth with glucuronic acid or inducing or activating a sulfotransferase to catalyze conjugation of an androgen involved in hair growth with a sulfonate to reduce mammalian androgen-stimulated hair growth, which comprises<div class="claim-text">selecting an area of skin from which hair grows in response to androgen-stimulation and from which reduced hair growth is desired; and</div> <div class="claim-text">applying to said area of skin a dermatologically acceptable composition comprising an effective amount of a compound that induces or activates said uridine diphosphate-glucouronosyltransferase to catalyze conjugation of said androgen with glucuronic acid or induces or activates said sulfotransferase to catalyze conjugation of said androgen with a sulfonate so that hair growth is reduced from said area of skin.</div> </div>
    </div>
    </div> <div class="claim"> <div num="2" class="claim">
      <div class="claim-text">2. A method of inducing or activating uridine diphosphate-glucouronosyltransferase to catalyze conjugation of an androgen involved in hair growth with glucuronic acid or inducing or activating a sulfotransferase to catalyze conjugation of an androgen involved in hair growth with a sulfonate to increase growth of mammalian hair that does not grow in response to androgen-stimulation, which comprises<div class="claim-text">selecting an area of skin from which hair that does not grow in response to androgen-stimulation and from which increased hair growth is desired; and</div> <div class="claim-text">applying to said area of skin a dermatologically acceptable composition comprising an effective amount of a compound that induces or activates said uridine diphosphate-glucouronosyltrasferase to catalyze conjugation of said androgen with glucuronic acid or induces or activates said sulfotransferase to catalyze conjugation of said androgen with a sulfonate so that hair growth is increased from said area of skin, wherein said compound is not flavone or a flavone derivative.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. The method of claim 1 or 2, wherein said compound comprises ethoxyquin.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. The method of claim 1, or wherein said compound comprises 5,7-dihydroxy-4'-methoxyflavone.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" class="claim">
      <div class="claim-text">5. The method of claim 1 or 2, wherein said compound comprises butylhydroxyanisole.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" class="claim">
      <div class="claim-text">6. The method of claim 1 or 2, wherein said compound comprises phenobarbital.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" class="claim">
      <div class="claim-text">7. The method of claim 1, wherein said compound comprises naringenin.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. The method of claim 1 or 2, wherein said compound comprises butylhydroxytoluene.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" class="claim">
      <div class="claim-text">9. The method of claim 1, wherein said compound comprises flavone.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" class="claim">
      <div class="claim-text">10. The method of claim 1 or 2, wherein said compound comprises tioconazole.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" class="claim">
      <div class="claim-text">11. The method of claim 1, wherein said compound comprises trans-1,2-bis(2-pyridyl)ethylene.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" class="claim">
      <div class="claim-text">12. The method of claim 1, wherein said compound comprises 7,4'-isoflavandiol.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="13" class="claim">
      <div class="claim-text">13. The method of claim 1, wherein said compound comprises galangin.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="14" class="claim">
      <div class="claim-text">14. The method of claim 1, wherein said compound comprises 7-hydroxy-4'-methoxyisoflavone.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="15" class="claim">
      <div class="claim-text">15. The method of claim 1, wherein said compound comprises 5,4'-dihydroxy-7-methoxyisoflavone.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="16" class="claim">
      <div class="claim-text">16. The method of claim 1, wherein said compound comprises daidzein.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="17" class="claim">
      <div class="claim-text">17. The method of claim 1, wherein said compound induces or activates the diphosphate-glucouronosyltransferase to catalyze conjugation of said androgen with glucuronic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="18" class="claim">
      <div class="claim-text">18. The method of claim 2, wherein said compound induces or activates the sulfotransferase to catalyze conjugation of said androgen with a sulfonate.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="19" class="claim">
      <div class="claim-text">19. The method of claim 1 or 2, wherein said androgen comprises testosterone.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="20" class="claim">
      <div class="claim-text">20. The method of claim 1 or 2, wherein the concentration of said compound in said composition is between 0.1% and 30%.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="21" class="claim">
      <div class="claim-text">21. The method of claim 1 or 2, wherein the composition provides a reduction in hair growth of at least 15% when tested in the Golden Syrian hamster assay.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="22" class="claim">
      <div class="claim-text">22. The method of claim 1 or 2, wherein the composition provides a reduction in hair growth of at least 40% when tested in the Golden Syrian hamster assay.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="23" class="claim">
      <div class="claim-text">23. The method of claim 1 or 2, wherein said mammal is a human.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="24" class="claim">
      <div class="claim-text">24. The method of claim 1, wherein the area of skin is on the face of the human.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="25" class="claim">
      <div class="claim-text">25. The method of claim 24, wherein said human is a woman suffering from hirsutism.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="26" class="claim">
      <div class="claim-text">26. The method of claim 2, wherein the area of skin is on the scalp of a human.</div>
    </div>
    </div> <div class="claim"> <div num="27" class="claim">
      <div class="claim-text">27. A method of conjugating an androgen that stimulates androgen-stimulated hair growth to produce a conjugate of said androgen that is more readily eliminated from the body than said androgen to reduce mammalian androgen-stimulated hair growth, which comprises<div class="claim-text">selecting an area of skin from which hair grows in response to androgen-stimulation and from which reduced hair growth is desired; and</div> <div class="claim-text">applying to said area of skin a dermatoligically acceptable composition comprising an effective amount of a compound that induces or activates the conjugation of said androgen to produce said conjugate so that hair growth is reduced from said area of skin.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="28" class="claim">
      <div class="claim-text">28. The method of claim 27, wherein the area of skin is on the face of a human.</div>
    </div>
    </div> <div class="claim"> <div num="29" class="claim">
      <div class="claim-text">29. A method of conjugating an androgen that retards growth of hair that does not grow in response to androgen-stimulation to increase growth of mammalian hair that does not grow in response to androgen-stimulation, which comprises<div class="claim-text">selecting an area of skin from which hair does not grow in response to androgen-stimulation and from which increased hair growth is desired; and</div> <div class="claim-text">applying to said area of skin a dermatologically acceptable composition comprising an effective amount of a compound that induces or activates the conjugation of said androgen to produce said conjugate so that hair growth is increased from said area of skin, wherein said compound is not flavone or a flavone derivative.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="30" class="claim">
      <div class="claim-text">30. The method of claim 29, wherein the area of skin includes the scalp of a human.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="31" class="claim">
      <div class="claim-text">31. The method of claim 27 or 29, wherein the compound is an inducer or activator of an androgen conjugation enzyme.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="32" class="claim">
      <div class="claim-text">32. The method of claim 31, wherein the androgen comprises a testosterone.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="33" class="claim">
      <div class="claim-text">33. The method of claim 31, wherein the androgen comprises dihydrotestosterone.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="34" class="claim">
      <div class="claim-text">34. The method of claim 31, wherein the androgen comprises an androgen selected from the group consisting of androstenedione, androstenediols, and dehydroepiandrosterone.</div>
    </div>
    </div> <div class="claim"> <div num="35" class="claim">
      <div class="claim-text">35. A method of inducing or activating conversion of testosterone to a less active metabolite to reduce mammalian androgen-stimulated hair growth, which comprises<div class="claim-text">selecting an area of skin from which hair grows in response to androgen-stimulation and from which reduced hair growth is desired; and</div> <div class="claim-text">applying to said area of skin a dermatologically acceptable composition comprising an effective amount of a compound that induces or activates the conversion of testosterone to said less active metabolite so that the hair growth is reduced form the area of skin.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="36" class="claim">
      <div class="claim-text">36. The method of claim 35, wherein the area of skin is on the face of a human.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="37" class="claim">
      <div class="claim-text">37. The method of claim 35, wherein the less active metabolite comprises a compound that is more water soluble than testosterone.</div>
    </div>
    </div> <div class="claim"> <div num="38" class="claim">
      <div class="claim-text">38. A method of inducing or activating conversion of testosterone to a less active metabolite to increase hair growth form the scalp of a human, which comprises<div class="claim-text">selecting an area of the scalp of a human and from which increase hair growth is desired; and</div> <div class="claim-text">applying to the area of the scalp a dermatologically acceptable composition comprising an effective amount a compound that induces or activates the conversion of testosterone to said less active metabolite so that hair growth increases from the area of the scalp, wherein said compound is not flavone or a flavone derivative.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="39" class="claim">
      <div class="claim-text">39. The method of claim 38, wherein the less active metabolite comprises a compound that is more water soluble than testosterone.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67341868" lang="EN" load-source="patent-office" class="description">
    <heading>BACKGROUND OF THE INVENTION</heading> <p>The invention relates to modulating hair growth in mammals.</p>
    <p>A main function of mammalian hair is to provide environmental protection. However, that function has largely been lost in humans, in whom hair is kept or removed from various parts of the body essentially for cosmetic reasons. For example, it is generally preferred to have hair on the scalp but not on the face.</p>
    <p>Various procedures have been employed to remove unwanted hair, including shaving, electrolysis, depilatory creams or lotions, waxing, plucking, and therapeutic antiandrogens. These conventional procedures generally have drawbacks associated with them. Shaving, for instance, can cause nicks and cuts, and can leave a perception of an increase in the rate of hair regrowth. Shaving also can leave an undesirable stubble. Electrolysis, on the other hand, can keep a treated area free of hair for prolonged periods of time, but can be expensive, painful, and sometimes leaves scarring. Depilatory creams, though very effective, typically are not recommended for frequent use due to their high irritancy potential. Waxing and plucking can cause pain, discomfort, and poor removal of short hair. Finally, antiandrogens--which have been used to treat female hirsutism--can have unwanted side effects.</p>
    <p>It has previously been disclosed that the rate and character of hair growth can be altered by applying to the skin inhibitors of certain enzymes. These inhibitors include inhibitors of 5-alpha reductase, ornithine decarboxylase, S-adenosylmethionine decarboxylase, gamma-glutamyl transpeptidase, and transglutaminase. See, for example, Breuer et al., U.S. Pat. No. 4,885,289; Shander, U.S. Pat. No. 4,720,489; Ahluwalia, U.S. Pat. No. 5,095,007; Ahluwalia et al., U.S. Pat. No. 5,096,911; Shander et al., U.S. Pat. No. 5,132,293; and Shander et al., U.S. Pat. No. 5,143,925.</p>
    <p>The growth of hair results from many complex and interactive processes. In one process sex steroid androgens, particularly testosterone, act on, for example, beard hair follicles on the face to stimulate hair growth. But these same androgens can inhibit hair growth on the scalp, particularly in those that have a genetic predisposition for male-pattern baldness or androgenetic alopecia.</p>
    <p>Cytochrome P450s, epoxide hydrolases, glutathione-S-transferases, uridine diphosphate-glucuronosyltransferases (UGTs), and sulfotransferases (STs) are families of enzymes that are involved in the metabolism of xenobiotics and other substances that are endogeneous to the human body. Generally, the enzymes catalyze the conversion of a substrate (e.g., a particular steroid) to a form that is more readily eliminated from the body. For example, glutathione-S-tranferases catalyze the conjugation of the substrate with glutathione; UGTs catalyze the conjugation of substrate with glucuronic acid; and STs catalyze the conjugation of the substrate with a sulfonate moiety. It is believed that these substrate conjugates are more water soluble than the substrate itself, and thus more readily eliminated from the body. Some of these enzymes can be induced by compounds, such as 3-methylcholanthrene and phenobarbital.</p>
    <p>Steroids are substrates for several isoforms of UGT, with overlapping specificities. For example, rat liver UGTr-3 catalyzes the glucuronidation of dihydrotestosterone, testosterone and β-estradiol, whereas in addition to these steroids UGTr-2 also catalyzes 4-hydroxybiphenyl, chloramphenicol and 4-methylumbelliferone glucuronoconjugation (Chen et al., Biochem. 32: 10648-10657).</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>In one aspect, the invention features modulating hair growth by topical application of a compound that induces or activates the conjugation of an androgen (e.g., testosterone) that is involved in hair growth. By "induces" or "activates", we mean that the compound increases the conjugating enzyme levels in the hair follicle cells and/or increases the catalytic activity of the conjugating enzyme for conjugation. The compound may, for example, induce or activate a UGT or an ST for which the androgen serves as the substrate.</p>
    <p>The modulation in hair growth depends on whether the hair growth selected for treatment is androgen-stimulated hair growth (e.g., beard hair and torso hair generally in humans) or hair growth that is not androgen-stimulated (e.g., scalp hair in humans). Topical application of the compound in a dermatologically acceptable vehicle to an area of skin having androgen-stimulated hair growth generally causes a reduction in hair growth. Topical application of the compound in a dermatologically acceptable vehicle to an area of skin having hair growth (i.e., from the scalp) that is reduced in the presence of androgens, (e.g., because of androgenic alopecia) generally causes an increase in hair growth.</p>
    <p>In another aspect, the invention features modulating hair growth by topical application of a compound that induces or activates a UGT.</p>
    <p>In another aspect, the invention features modulating hair growth by topical application of a compound that induces or activates an ST.</p>
    <p>In another aspect, the invention features modulating hair growth by topical application of a compound that induces or activates the conversion of an androgen involved in hair growth to a less active (e.g., more water soluble) metabolite.</p>
    <p>Other features and advantages of the invention will be apparent from the Description of Preferred Embodiments thereof, and from the claims.</p>
    <heading>DESCRIPTION OF PREFERRED EMBODIMENTS</heading> <p>Compounds that activate or induce UGTs are known. Such compounds include ethoxyquin, 5,7-dihydroxy-4'-methoxyflavone, butylhydroxyanisole, phenobarbital, naringenin, butylhydroxytoluene, flavone, tioconazole, trans-1,2-bis(2-pyridyl)ethylene, 7,4'-isoflavandiol, (equol), galangin, 7-hydroxy-4'-methoxyisoflavone (formononetin), 5,4'-dihydroxy-7-methoxyisoflavone (prunetin), and daidzein. These compounds induce UGTs relevant to testosterone glucononidation.</p>
    <p>Examples of androgens that may be conjugated include testosterone, dihydrotestosterone, androstenedione, androstenediols, and dehydroepiandrosterone.</p>
    <p>It is believed that the compounds act according to the pathway shown below (in which testosterone is used as an example): ##STR1##</p>
    <p>The compound may induce or activate, for example, UGTs that catalyze the conjugation of testosterone with glucuronic acid (donated from uridine diphosphoglucuronic acid) or STs that catalyze the conjugation of testosterone with a sulfonate group (donated from 3'-phosphoadenosine 5'-phosphosulfate).</p>
    <p>The compound preferably is incorporated in a topical composition that includes a non-toxic dermatologically acceptable vehicle or carrier which is adapted to be spread upon the skin. Examples of suitable vehicles are acetone, alcohols, or a cream, lotion, or gel which can effectively deliver the active compound. A vehicle is disclosed in U.S. Pat. No. 5,648,394. In addition, a penetration enhancer may be added to the vehicle to further enhance the effectiveness of the formulation.</p>
    <p>The concentration of the compound in the composition may be varied over a wide range up to a saturated solution, preferably from 0.1% to 30% by weight or even more; the reduction or increase in hair growth rises as the amount of inhibitor applied increases per unit area of skin. The maximum amount effectively applied is limited only by the rate at which the compound penetrates the skin. The effective amounts may range, for example, from 10 to 3000 micrograms or more per square centimeter of skin.</p>
    <p>A composition may include more than one of the compounds.</p>
    <p>The composition should be topically applied to a selected area of the body from which it is desired to reduce hair growth (if the hair growth is androgen-stimulated hair growth) or increase hair growth (if the hair loss is androgen dependent). For example, in humans the composition can be applied to the face, particularly to the beard area of the face, i.e., the cheek, neck, upper lip, and chin to obtain a reduction in hair growth. The composition can also be applied to the legs, arms, torso or armpits to obtain a reduction in hair growth. The composition can be applied to the scalp to obtain an increase in hair growth. The composition is particularly suitable for reducing the growth of unwanted hair in women suffering from hirsutism or other similar conditions.</p>
    <p>In humans, the composition, for example, may be applied once or twice a day, or even more frequently, for two weeks to six months (e.g., three months) to achieve a perceived effect. Reduction in hair growth is demonstrated when the frequency of hair removal is reduced or the subject perceives less hair on the treated site, or quantitatively, when the weight of hair removed by shaving (i.e., hair mass) is reduced. Increase in hair growth is demonstrated when the opposite effect is observed.</p>
    <p>Male intact Golden Syrian hamsters are considered acceptable models for human beard hair growth and other androgen-stimulated hair growth in that they display oval shaped flank organs, one on each side, each about 8 mm. in major diameter, which grow thick black and coarse hair similar to human beard hair. These organs produce hair in response to androgens in the hamster. To evaluate the effectiveness of a composition in reducing androgen-stimulated hair growth, the flank organs of each of a group of hamsters are shaved. To one organ of each animal 10 μl. of composition vehicle alone once a day is applied, while to the other organ of each animal an equal amount of the composition (including the relevant compound or compounds). After thirteen applications (one application per day for five days a week), the flank organs are shaved and the amount of recovered hair (hair mass) from each is weighed. Percent-reduction of hair growth is calculated by subtracting the hair mass (mg) value of the test compound treated side from the hair mass value of the vehicle treated side; the delta value obtained is then divided by the hair mass value of the vehicle treated side, and the resultant number is multiplied by 100.</p>
    <p>The above-described assay will be referred to herein as the "Golden Syrian hamster" assay. Preferred compositions provide a reduction in hair growth of at least about 30%, more preferably at least about 50%, and most preferably at least about 60% when tested in the Golden Syrian hamster assay.</p>
    <p>A number of compositions containing compounds that induce or activate UGTs for which testosterone is a substrate were tested in the Golden Syrian hamster assay; the results are provided in Table I:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">                                  TABLE I__________________________________________________________________________Compound       Vehicle               Left(mg)                     Right(mg)                           % Inhibition__________________________________________________________________________ethoxyquin     A    0.55 ± .16                     2.41 ± .11                           75 ± 75,7-dihydroxy-4'-methoxyflavone          B    1.00 ± .22                     2.61 ± .27                           62 ± 9butylhydroxyanisole          A    0.92 ± .24                     2.27 ± .11                           61 ± 9phenobarbital  A    0.89 ± .16                     1.88 ± .24                            51 ± 11naringenin     A    1.42 ± .18                     2.46 ± .20                           40 ± 8butylhydroxytoluene          C    1.74 ± .38                     2.05 ± .36                            22 ± 18flavanone      C    1.91 ± .22                     2.39 ± .22                            17 ± 10__________________________________________________________________________ All compounds were administered as a 10% does. Vehicle A = ethanol 80%, H<sub>2</sub> O 17.5%, propylene glycol dipelargonate 2%, propylene glycol 0.5% B = ethanol 70%, dimethylsulfoxamine 30%; C = propylene glycol 50%, ethanol 25%, dimethylsulfoxide 25%.</pre>
    
    <p>An assay was performed to evaluate whether some of the compounds tested in the Golden Syrian Hamster assay caused an induction of testosterone glucuronide formation.</p>
    <p>Flank organ homogenates were prepared by adding 4 flank organs into 2 mL of a buffer containing 25 mM Tris/50 mM sucrose, pH 7.4 and homogenized with a Polytron (Brinkman Instruments) while keeping the mixture on ice. The glucuronidation of testosterone was measured by incubating the 20 μl of the flank organ protein (1 mg/ml) with  <sup>14</sup> C!-testosterone testosterone 125 μM and UDP-glucuronic acid (5 mM) in the presence of buffer containing 0.5M Tris, pH 7.5 and 0.1M MgCl<sub>2</sub>. The total reaction mixture volume was 100 μl. Assay mixtures were incubated at 37° C. for 60 minutes, and reactions were stopped with the addition of 3.5 ml methylene chloride. An aqueous carrier (250 μl water) was added to each reaction mixture which was then shaken and centrifuged. The unmetabolized  <sup>14</sup> C!-testosterone remained in the organic phase whereas the testosterone glucuronide partitioned into the aqueous phase, and was quantitated by scintillation spectrometry. The results are provided in Table II:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE II______________________________________Compound            % Induction______________________________________ethoxyquin          214butylhydroxyanisole 1785,7-dihydroxy-4'-methoxyflavone               120phenobarbital       113______________________________________</pre>
    
    <p>It was believed that the diversion of testosterone away from its biologically active species to a glucuronide or sulfonate conjugate would have effects on the flank organs of the Golden Syrian hamster since testosterone is known to regulate the existence of these unique organs. The diameter of flank organs were assessed using a caliper following topical treatment of the hamsters with ethoxyquin or 5,7-dihydroxy-4'-methoxyflavone as described in the hair mass assay section. A decrease in flank organ diameter was demonstrated following topical application of the compounds (Table III). These data are consistent with the hypothesis that suggests that local induction of conjugating enzymes, such as UGTs, can diminish the biological activity of testosterone.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">                                  TABLE III__________________________________________________________________________          Treated FO                Vehicle FO                      DecreaseTreatment      (mm)  (mm)  (mm)  % Decrease__________________________________________________________________________ethoxyquin     7.18 ± .26                8.83 ± .28                      1.65 ± .37                            19 ± 45,7-dihydroxy-4'-methoxyflavone          8.04 ± .29                9.08 ± .43                      1.04 ± .46                            12 ± 5__________________________________________________________________________</pre>
    
    <p>Other embodiments are within the claims.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3426137">US3426137</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 23, 1965</td><td class="patent-data-table-td patent-date-value">Feb 4, 1969</td><td class="patent-data-table-td ">Olin Mathieson</td><td class="patent-data-table-td ">Hair growth inhibiting by aminobenzophenones</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4039669">US4039669</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 1, 1975</td><td class="patent-data-table-td patent-date-value">Aug 2, 1977</td><td class="patent-data-table-td ">Sterling Drug Inc.</td><td class="patent-data-table-td ">Composition for topical application and use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4139638">US4139638</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 3, 1977</td><td class="patent-data-table-td patent-date-value">Feb 13, 1979</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">Methods for the treatment of hirsutism</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4161540">US4161540</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 3, 1977</td><td class="patent-data-table-td patent-date-value">Jul 17, 1979</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">Antiandrogenic agents and methods for the treatment of androgen dependent disease states</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4191775">US4191775</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 29, 1978</td><td class="patent-data-table-td patent-date-value">Mar 4, 1980</td><td class="patent-data-table-td ">Imperial Chemical Industries Limited</td><td class="patent-data-table-td ">Amide derivatives</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4269831">US4269831</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 9, 1979</td><td class="patent-data-table-td patent-date-value">May 26, 1981</td><td class="patent-data-table-td ">Sterling Drug Inc.</td><td class="patent-data-table-td ">Topical dermatological method of use of an androstenopyrazole</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4370315">US4370315</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 22, 1978</td><td class="patent-data-table-td patent-date-value">Jan 25, 1983</td><td class="patent-data-table-td ">Sederma</td><td class="patent-data-table-td ">Lipoxygenase, linoleic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4439432">US4439432</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 22, 1982</td><td class="patent-data-table-td patent-date-value">Mar 27, 1984</td><td class="patent-data-table-td ">Peat Raymond F</td><td class="patent-data-table-td ">Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4508714">US4508714</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 14, 1983</td><td class="patent-data-table-td patent-date-value">Apr 2, 1985</td><td class="patent-data-table-td ">Tihomir Cecic</td><td class="patent-data-table-td ">Tincture of cinchona, quillaia, and eucalyptus with ethanol and water</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4517175">US4517175</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 23, 1983</td><td class="patent-data-table-td patent-date-value">May 14, 1985</td><td class="patent-data-table-td ">Kao Corporation</td><td class="patent-data-table-td ">Flavanol derivatives and proteins</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4720489">US4720489</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 15, 1984</td><td class="patent-data-table-td patent-date-value">Jan 19, 1988</td><td class="patent-data-table-td ">Douglas Shander</td><td class="patent-data-table-td ">Hair growth modification with ornithine decarboxylase inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4885289">US4885289</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 11, 1985</td><td class="patent-data-table-td patent-date-value">Dec 5, 1989</td><td class="patent-data-table-td ">Breuer Miklos M</td><td class="patent-data-table-td ">Alteration of character of male beard growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4935231">US4935231</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 4, 1988</td><td class="patent-data-table-td patent-date-value">Jun 19, 1990</td><td class="patent-data-table-td ">Repligen Corporation</td><td class="patent-data-table-td ">Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5095007">US5095007</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 24, 1990</td><td class="patent-data-table-td patent-date-value">Mar 10, 1992</td><td class="patent-data-table-td ">Ahluwalia Gurpreet S</td><td class="patent-data-table-td ">Enzyme inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5096911">US5096911</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 25, 1990</td><td class="patent-data-table-td patent-date-value">Mar 17, 1992</td><td class="patent-data-table-td ">Ahluwalia Gurpreet S</td><td class="patent-data-table-td ">Alteration of rate and character of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5132293">US5132293</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 28, 1991</td><td class="patent-data-table-td patent-date-value">Jul 21, 1992</td><td class="patent-data-table-td ">Douglas Shander</td><td class="patent-data-table-td ">Enzyme inhibitors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5143925">US5143925</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 12, 1991</td><td class="patent-data-table-td patent-date-value">Sep 1, 1992</td><td class="patent-data-table-td ">Douglas Shander</td><td class="patent-data-table-td ">Alteration of rate and character of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5189212">US5189212</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 7, 1990</td><td class="patent-data-table-td patent-date-value">Feb 23, 1993</td><td class="patent-data-table-td ">University Of Georgia Research Foundation, Inc.</td><td class="patent-data-table-td ">Used in estrogen replacement therapy like menopause, osteoporosis therapy, prevention of excessive hair growth of body and infertility</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5271942">US5271942</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 25, 1991</td><td class="patent-data-table-td patent-date-value">Dec 21, 1993</td><td class="patent-data-table-td ">Ulrich Heverhagen</td><td class="patent-data-table-td ">Agent for reducing the growth of or removing the hair on the human body</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5300284">US5300284</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 28, 1992</td><td class="patent-data-table-td patent-date-value">Apr 5, 1994</td><td class="patent-data-table-td ">Chesebrough-Pond&#39;s Usa Co., Division Of Conopco, Inc.</td><td class="patent-data-table-td ">Breaking the hydrogen bonding between sugar-like molecules to prevent stickiness and stiffness</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5364885">US5364885</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 13, 1992</td><td class="patent-data-table-td patent-date-value">Nov 15, 1994</td><td class="patent-data-table-td ">Ahluwalia Gurpreet S</td><td class="patent-data-table-td ">Reduction of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5411991">US5411991</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 22, 1992</td><td class="patent-data-table-td patent-date-value">May 2, 1995</td><td class="patent-data-table-td ">Shander; Douglas</td><td class="patent-data-table-td ">Applying to human skin, beards, reaction with cysteine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5455234">US5455234</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 16, 1994</td><td class="patent-data-table-td patent-date-value">Oct 3, 1995</td><td class="patent-data-table-td ">Ahluwalia; Gurpreet S.</td><td class="patent-data-table-td ">Inhibition of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5474763">US5474763</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 11, 1994</td><td class="patent-data-table-td patent-date-value">Dec 12, 1995</td><td class="patent-data-table-td ">Shander; Douglas</td><td class="patent-data-table-td ">Reduction of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5554608">US5554608</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 28, 1994</td><td class="patent-data-table-td patent-date-value">Sep 10, 1996</td><td class="patent-data-table-td ">Ahluwalia; Gurpreet S.</td><td class="patent-data-table-td ">Inhibition of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5648394">US5648394</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 27, 1993</td><td class="patent-data-table-td patent-date-value">Jul 15, 1997</td><td class="patent-data-table-td ">Boxall; Brian Alfred</td><td class="patent-data-table-td ">Topical composition for inhibiting hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0413528A1?cl=en">EP0413528A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 10, 1990</td><td class="patent-data-table-td patent-date-value">Feb 20, 1991</td><td class="patent-data-table-td ">Ruey J. Dr. Yu</td><td class="patent-data-table-td ">Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0532219A2?cl=en">EP0532219A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 2, 1992</td><td class="patent-data-table-td patent-date-value">Mar 17, 1993</td><td class="patent-data-table-td ">Unilever Plc</td><td class="patent-data-table-td ">Cosmetic composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=xkRMBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DGB%26NR%3D1458349A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNGwqPd5qxw0RKjknubhHGMmJoxGeQ">GB1458349A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1996010387A2?cl=en">WO1996010387A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 28, 1995</td><td class="patent-data-table-td patent-date-value">Apr 11, 1996</td><td class="patent-data-table-td ">Stephen Peter Barton</td><td class="patent-data-table-td ">Hair stimulant composition</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Adachi et al., "<a href='http://scholar.google.com/scholar?q="Human+Hair+Follicles%3A+Metabolism+and+Control+Mechanisms"'>Human Hair Follicles: Metabolism and Control Mechanisms</a>", Journal of the Society of Cosmetic Chemists, 21, 901-924, Dec. 9, 1970.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Adachi et al., Human Hair Follicles: Metabolism and Control Mechanisms , Journal of the Society of Cosmetic Chemists, 21, 901 924, Dec. 9, 1970.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Andrew G. Messenger, "<a href='http://scholar.google.com/scholar?q="The+Control+of+Hair+Growth%3A+An+Overview"'>The Control of Hair Growth: An Overview</a>", The Society for Investigative Dermatology, Inc., 1993.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Andrew G. Messenger, The Control of Hair Growth: An Overview , The Society for Investigative Dermatology, Inc., 1993.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">CA 123:4198, Kudlacek et, 1995.</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">CA 125:293042, Ahlowaha et al, 1996.</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Chen et al., "<a href='http://scholar.google.com/scholar?q="Characterization+of+a+Cloned+Human+Dihydrotestosterone%2FAndrostanediol+UDP-Glucuronosyltrans-ferase+and+Its+Comparison+to+Other+Steroid+Isoforms"'>Characterization of a Cloned Human Dihydrotestosterone/Androstanediol UDP-Glucuronosyltrans-ferase and Its Comparison to Other Steroid Isoforms</a>", Biochemistry, vol. 32, No. 40, 10648-57, 1993.</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Chen et al., Characterization of a Cloned Human Dihydrotestosterone/Androstanediol UDP Glucuronosyltrans ferase and Its Comparison to Other Steroid Isoforms , Biochemistry, vol. 32, No. 40, 10648 57, 1993.</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Green et al., "<a href='http://scholar.google.com/scholar?q="Cloning+and+Expression+of+a+Rat+Liver+Phenobarbital-Inducible+UDP-Glucuronosyltransferase+%282B12%29+with+Specificity+for+Monoterpenoid+Alcohols"'>Cloning and Expression of a Rat Liver Phenobarbital-Inducible UDP-Glucuronosyltransferase (2B12) with Specificity for Monoterpenoid Alcohols</a>", Arch. of Biochem. &amp; Biophysics, vol. 322, Oct. 1, 1995.</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Green et al., Cloning and Expression of a Rat Liver Phenobarbital Inducible UDP Glucuronosyltransferase (2B12) with Specificity for Monoterpenoid Alcohols , Arch. of Biochem. &amp; Biophysics, vol. 322, Oct. 1, 1995.</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">J. Baron, "<a href='http://scholar.google.com/scholar?q="In+situ+sites+for+xenobiotic+activation+and+detoxication%3A+Implications+for+the+differential+susceptibility+of+cells+to+the+toxic+.+.+.+"'>In situ sites for xenobiotic activation and detoxication: Implications for the differential susceptibility of cells to the toxic . . . </a>", Progress in Histo-and Cytochemistry, vol. 23, 1991.</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">J. Baron, In situ sites for xenobiotic activation and detoxication: Implications for the differential susceptibility of cells to the toxic . . . , Progress in Histo and Cytochemistry, vol. 23, 1991.</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kashfi et al., "<a href='http://scholar.google.com/scholar?q="Regulation+of+Uridine+Diphosphate+Glucuronosyltransferase+Expression+by+Phenolic+Antioxidants"'>Regulation of Uridine Diphosphate Glucuronosyltransferase Expression by Phenolic Antioxidants</a>", Cancer Research, 54, pp. 5856-5859, Nov. 15, 1994.</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Kashfi et al., Regulation of Uridine Diphosphate Glucuronosyltransferase Expression by Phenolic Antioxidants , Cancer Research, 54, pp. 5856 5859, Nov. 15, 1994.</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Marty E. Sawaya, "<a href='http://scholar.google.com/scholar?q="Steroid+Chemistry+and+Hormone+Controls+during+the+Hair+Follicle+Cycle"'>Steroid Chemistry and Hormone Controls during the Hair Follicle Cycle</a>", Annals New York Academy of Sciences, pp. 376-384 (Undated).</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Marty E. Sawaya, Steroid Chemistry and Hormone Controls during the Hair Follicle Cycle , Annals New York Academy of Sciences, pp. 376 384 (Undated).</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Michael R. Franklin, "<a href='http://scholar.google.com/scholar?q="Drug+Metabolizing+Enzyme+Induction+by+Simple+Diaryl+Pydridines%3B+2-Substituted+Isomers+Selectively+Increase+Only+Conjugation+Enzyme+Activities+.+.+.+"'>Drug Metabolizing Enzyme Induction by Simple Diaryl Pydridines; 2-Substituted Isomers Selectively Increase Only Conjugation Enzyme Activities . . . </a>", Toxicology and Applied Pharmacology, 111, 1991.</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Michael R. Franklin, Drug Metabolizing Enzyme Induction by Simple Diaryl Pydridines; 2 Substituted Isomers Selectively Increase Only Conjugation Enzyme Activities . . . , Toxicology and Applied Pharmacology, 111, 1991.</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Pegg et al., "<a href='http://scholar.google.com/scholar?q="Fundam.+Appl.+Toxicol."'>Fundam. Appl. Toxicol.</a>", vol. 32(1):45-32, (1996) (Abstract only).</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Pegg et al., Fundam. Appl. Toxicol. , vol. 32(1):45 32, (1996) (Abstract only).</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Pritchard et al., "<a href='http://scholar.google.com/scholar?q="A+Recombinant+Phenobarbital-Inducible+Rat+Liver+UDP-Glucoronsyltransferase+%28UDP-Glucuro-nosyltransferase+2B1%29+Stably+Expressed+in+V79+Cells+Catalyzes+.+.+.+"'>A Recombinant Phenobarbital-Inducible Rat Liver UDP-Glucoronsyltransferase (UDP-Glucuro-nosyltransferase 2B1) Stably Expressed in V79 Cells Catalyzes . . . </a>" Molecular Pharmacology, 45:42-50, 1993.</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Pritchard et al., A Recombinant Phenobarbital Inducible Rat Liver UDP Glucoronsyltransferase (UDP Glucuro nosyltransferase 2B1) Stably Expressed in V79 Cells Catalyzes . . . Molecular Pharmacology, 45:42 50, 1993.</td></tr><tr><td class="patent-data-table-td ">23</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ritter et al., "<a href='http://scholar.google.com/scholar?q="Induction+of+Hepatic+Oxidative+and+Conjugative+Drug+Metabolism+in+the+Hamster+by+N-Substituted+Imidazoles"'>Induction of Hepatic Oxidative and Conjugative Drug Metabolism in the Hamster by N-Substituted Imidazoles</a>", Toxicology Letters, 36, pp. 51-59, 1987.</td></tr><tr><td class="patent-data-table-td ">24</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ritter et al., Induction of Hepatic Oxidative and Conjugative Drug Metabolism in the Hamster by N Substituted Imidazoles , Toxicology Letters, 36, pp. 51 59, 1987.</td></tr><tr><td class="patent-data-table-td ">25</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Schweikert et al., Regulation of Human Hair Growth by Steroid Hormones, JCE&amp;M, vol. 38, No. 5, 1974.</td></tr><tr><td class="patent-data-table-td ">26</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Sun et al., "<a href='http://scholar.google.com/scholar?q="Flavonoids+increased+the+activity+of+Testosterone+Glucuronosyltransferase+%28GT%29+in+prostate+cancer+cells"'>Flavonoids increased the activity of Testosterone Glucuronosyltransferase (GT) in prostate cancer cells</a>", Proceedings of the American Association for Cancer Research, vol. 36, Mar. 1995 (Abstract).</td></tr><tr><td class="patent-data-table-td ">27</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Sun et al., Flavonoids increased the activity of Testosterone Glucuronosyltransferase (GT) in prostate cancer cells , Proceedings of the American Association for Cancer Research, vol. 36, Mar. 1995 (Abstract).</td></tr><tr><td class="patent-data-table-td ">28</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Tephyl et al., "<a href='http://scholar.google.com/scholar?q="UDP-glucuronosyltransferases%3A+a+family+of+detoxifying+enzymes"'>UDP-glucuronosyltransferases: a family of detoxifying enzymes</a>", TIPS Reviews, Jul. 1990.</td></tr><tr><td class="patent-data-table-td ">29</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Tephyl et al., UDP glucuronosyltransferases: a family of detoxifying enzymes , TIPS Reviews, Jul. 1990.</td></tr><tr><td class="patent-data-table-td ">30</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Wong et al., "<a href='http://scholar.google.com/scholar?q="Differential+Induction+of+UDP-Glucuronosyltransferase+Activity+and+Gene+Expression+in+Rat+Liver"'>Differential Induction of UDP-Glucuronosyltransferase Activity and Gene Expression in Rat Liver</a>", Pharmaceutical Research, vol. 12, No. 7, 1995.</td></tr><tr><td class="patent-data-table-td ">31</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Wong et al., Differential Induction of UDP Glucuronosyltransferase Activity and Gene Expression in Rat Liver , Pharmaceutical Research, vol. 12, No. 7, 1995.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6235737">US6235737</a></td><td class="patent-data-table-td patent-date-value">Jan 25, 2000</td><td class="patent-data-table-td patent-date-value">May 22, 2001</td><td class="patent-data-table-td ">Peter Styczynski</td><td class="patent-data-table-td ">Reduction of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6299865">US6299865</a></td><td class="patent-data-table-td patent-date-value">May 2, 2000</td><td class="patent-data-table-td patent-date-value">Oct 9, 2001</td><td class="patent-data-table-td ">Peter Styczynski</td><td class="patent-data-table-td ">Selecting area of skin; applying alkaline phosphatase inhibitor other than cromoglycate or its salt to reduce hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6486147">US6486147</a></td><td class="patent-data-table-td patent-date-value">Apr 10, 2001</td><td class="patent-data-table-td patent-date-value">Nov 26, 2002</td><td class="patent-data-table-td ">L&#39;oreal</td><td class="patent-data-table-td ">Cosmetic composition containing a steroid and a 2-alkylalkanol or an ester thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6743822">US6743822</a></td><td class="patent-data-table-td patent-date-value">Jul 17, 2002</td><td class="patent-data-table-td patent-date-value">Jun 1, 2004</td><td class="patent-data-table-td ">The Gillette Company</td><td class="patent-data-table-td ">Applying to area of skin a dermatologically acceptable composition comprising alpha -difluoromethylornithine in an amount effective to reduce hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6747017">US6747017</a></td><td class="patent-data-table-td patent-date-value">Dec 28, 1998</td><td class="patent-data-table-td patent-date-value">Jun 8, 2004</td><td class="patent-data-table-td ">Kao Corporation</td><td class="patent-data-table-td ">Endopeptidase inhibitor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7015349">US7015349</a></td><td class="patent-data-table-td patent-date-value">Mar 26, 2003</td><td class="patent-data-table-td patent-date-value">Mar 21, 2006</td><td class="patent-data-table-td ">The Gillette Company</td><td class="patent-data-table-td ">A conjugate of alpha -difluoromethylornithine can be applied topically to reduce hair growth from the area of skin in on the face, legs or underarm</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7160921">US7160921</a></td><td class="patent-data-table-td patent-date-value">Aug 7, 2003</td><td class="patent-data-table-td patent-date-value">Jan 9, 2007</td><td class="patent-data-table-td ">The Gillette Company</td><td class="patent-data-table-td ">Reduction of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7261878">US7261878</a></td><td class="patent-data-table-td patent-date-value">Jul 17, 2002</td><td class="patent-data-table-td patent-date-value">Aug 28, 2007</td><td class="patent-data-table-td ">The Gillette Company</td><td class="patent-data-table-td ">Reduction of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7345192">US7345192</a></td><td class="patent-data-table-td patent-date-value">Nov 10, 2005</td><td class="patent-data-table-td patent-date-value">Mar 18, 2008</td><td class="patent-data-table-td ">The Gillette Company</td><td class="patent-data-table-td ">Reduction of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7396855">US7396855</a></td><td class="patent-data-table-td patent-date-value">Jul 24, 2003</td><td class="patent-data-table-td patent-date-value">Jul 8, 2008</td><td class="patent-data-table-td ">Children&#39;s Hospital Medical Center</td><td class="patent-data-table-td ">Foods; skin, lipid, liver, and cardiovascular disorders; hormone dependent diseases, osteopenia, osteoporosis,and acute ovarian estrogen deficiency; biosynthesis by metabolism of isoflavone; drug delivery</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7439271">US7439271</a></td><td class="patent-data-table-td patent-date-value">Jun 27, 2001</td><td class="patent-data-table-td patent-date-value">Oct 21, 2008</td><td class="patent-data-table-td ">The Gillette Company</td><td class="patent-data-table-td ">Reduction of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7618956">US7618956</a></td><td class="patent-data-table-td patent-date-value">May 31, 2005</td><td class="patent-data-table-td patent-date-value">Nov 17, 2009</td><td class="patent-data-table-td ">The Gillette Company</td><td class="patent-data-table-td ">Reduction of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7727516">US7727516</a></td><td class="patent-data-table-td patent-date-value">Feb 22, 2007</td><td class="patent-data-table-td patent-date-value">Jun 1, 2010</td><td class="patent-data-table-td ">The Procter &amp; Gamble Company</td><td class="patent-data-table-td ">Reduction of hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7960432">US7960432</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2008</td><td class="patent-data-table-td patent-date-value">Jun 14, 2011</td><td class="patent-data-table-td ">Children&#39;s Hospital Medical Center</td><td class="patent-data-table-td ">Compositions and products containing S-equol, and methods for their making</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7985404">US7985404</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 21, 2000</td><td class="patent-data-table-td patent-date-value">Jul 26, 2011</td><td class="patent-data-table-td ">Johnson &amp; Johnson Consumer Companies, Inc.</td><td class="patent-data-table-td ">Reducing hair growth, hair follicle and hair shaft size and hair pigmentation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8048913">US8048913</a></td><td class="patent-data-table-td patent-date-value">Sep 14, 2009</td><td class="patent-data-table-td patent-date-value">Nov 1, 2011</td><td class="patent-data-table-td ">Australian Health &amp; Nutrition Assoc. Ltd.</td><td class="patent-data-table-td ">Compositions and products containing S-equol, and methods for their making</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8153684">US8153684</a></td><td class="patent-data-table-td patent-date-value">Oct 2, 2009</td><td class="patent-data-table-td patent-date-value">Apr 10, 2012</td><td class="patent-data-table-td ">Colorado State University Research Foundation</td><td class="patent-data-table-td ">Use of equol for treating androgen mediated diseases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8282946">US8282946</a></td><td class="patent-data-table-td patent-date-value">Oct 11, 2005</td><td class="patent-data-table-td patent-date-value">Oct 9, 2012</td><td class="patent-data-table-td ">Kao Corporaion</td><td class="patent-data-table-td ">Water-soluble ginger root extract</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8344021">US8344021</a></td><td class="patent-data-table-td patent-date-value">Jun 20, 2007</td><td class="patent-data-table-td patent-date-value">Jan 1, 2013</td><td class="patent-data-table-td ">L&#39;oreal</td><td class="patent-data-table-td ">Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the treatment of canities</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8450364">US8450364</a></td><td class="patent-data-table-td patent-date-value">Apr 9, 2012</td><td class="patent-data-table-td patent-date-value">May 28, 2013</td><td class="patent-data-table-td ">Brigham Young University</td><td class="patent-data-table-td ">Use of equol for treating androgen mediated diseases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8580846">US8580846</a></td><td class="patent-data-table-td patent-date-value">Aug 18, 2006</td><td class="patent-data-table-td patent-date-value">Nov 12, 2013</td><td class="patent-data-table-td ">Brigham Young University</td><td class="patent-data-table-td ">Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8591874">US8591874</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 1, 2006</td><td class="patent-data-table-td patent-date-value">Nov 26, 2013</td><td class="patent-data-table-td ">The Procter &amp; Gamble Company</td><td class="patent-data-table-td ">Inhibition of mammalian hair growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8668914">US8668914</a></td><td class="patent-data-table-td patent-date-value">Jul 31, 2009</td><td class="patent-data-table-td patent-date-value">Mar 11, 2014</td><td class="patent-data-table-td ">Brigham Young University</td><td class="patent-data-table-td ">Use of equol for treating skin diseases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8691518">US8691518</a></td><td class="patent-data-table-td patent-date-value">Sep 26, 2011</td><td class="patent-data-table-td patent-date-value">Apr 8, 2014</td><td class="patent-data-table-td ">Global Life Science Partners Limited</td><td class="patent-data-table-td ">Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/CN101095650B?cl=en">CN101095650B</a></td><td class="patent-data-table-td patent-date-value">Jun 19, 2007</td><td class="patent-data-table-td patent-date-value">Sep 19, 2012</td><td class="patent-data-table-td ">莱雅公司</td><td class="patent-data-table-td ">Use of coumarin, butylated hydroxyanisole and ethoxyquin for treating grey hair</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1870087A2?cl=en">EP1870087A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 15, 2007</td><td class="patent-data-table-td patent-date-value">Dec 26, 2007</td><td class="patent-data-table-td ">L&#39;Oréal</td><td class="patent-data-table-td ">Use of coumarin, butylated hydroxyanisole and ethoxyquin for treating grey hair</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013049258A1?cl=en">WO2013049258A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 26, 2012</td><td class="patent-data-table-td patent-date-value">Apr 4, 2013</td><td class="patent-data-table-td ">Follea International</td><td class="patent-data-table-td ">Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S311000">514/311</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S718000">514/718</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S719000">514/719</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S731000">514/731</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S270000">514/270</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S453000">514/453</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S456000">514/456</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031075000">A61K31/075</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0008340000">A61K8/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0008630000">A61K8/63</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031515000">A61K31/515</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61Q0007000000">A61Q7/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61Q0007020000">A61Q7/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0008490000">A61K8/49</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031045000">A61K31/045</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031470000">A61K31/47</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031350000">A61K31/35</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/347">A61K8/347</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/515">A61K31/515</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/498">A61K8/498</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/63">A61K8/63</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/49">A61K8/49</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/045">A61K31/045</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/075">A61K31/075</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61Q7/00">A61Q7/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61Q7/02">A61Q7/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/35">A61K31/35</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/492">A61K8/492</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/47">A61K31/47</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/4953">A61K8/4953</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=xkRMBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/4926">A61K8/4926</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61K31/515</span>, <span class="nested-value">A61Q7/00</span>, <span class="nested-value">A61K8/49</span>, <span class="nested-value">A61K8/49C4</span>, <span class="nested-value">A61K8/49C2C</span>, <span class="nested-value">A61K31/47</span>, <span class="nested-value">A61K8/49F2</span>, <span class="nested-value">A61K8/63</span>, <span class="nested-value">A61K31/35</span>, <span class="nested-value">A61Q7/02</span>, <span class="nested-value">A61K8/34F</span>, <span class="nested-value">A61K31/045</span>, <span class="nested-value">A61K31/075</span>, <span class="nested-value">A61K8/49H2</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Feb 18, 2011</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 20, 2007</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 31, 2006</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">THE PATENTABILITY OF CLAIMS 2, 18, 26, 29 AND 30 IS CONFIRMED. CLAIMS 4, 8, 9 AND 12-16 ARE CANCELLED. CLAIMS 1, 10, 21, 22, 27, 35 AND 38 ARE DETERMINED TO BE PATENTABLE AS AMENDED. CLAIMS 3, 5-7, 11, 17, 19, 20, 23-25, 28, 31-34, 36, 37 AND 39, DEPENDENT ON AN AMENDED CLAIM, ARE DETERMINED TO BE PATENTABLE. NEW CLAIMS 40-49 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 27, 2004</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20031205</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 18, 2003</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">GILLETTE COMPANY, THE (A DELAWARE CORPORATION), MA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:STYCZYNSKI, PETER;AHLUWALIA, GURPREET;REEL/FRAME:013991/0839</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19981026</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">GILLETTE COMPANY, THE (A DELAWARE CORPORATION) PRU</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Mar 27, 2003</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U1aKHbABJfQCo2J_B_YaUE9Xwco5A\u0026id=xkRMBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2kenCbCKAwx28Y0mY6sgl3iLQK2g\u0026id=xkRMBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U0dOfDiUIUHCzpSNWw3_nLovmNfBg","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Applying_glucuronic_acid.pdf?id=xkRMBAABERAJ\u0026output=pdf\u0026sig=ACfU3U3xlMUJ_lintoJ082noTAzDQJyikA"},"sample_url":"http://www.google.com/patents/reader?id=xkRMBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>